OdDHL inhibits T cell subset differentiation and delays diabetes onset in NOD mice

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1213-1220

  Gaisford, Wendy ^a   Pritchard, David I ^b   Cooke, Anne ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; N (3 OXODODECANOYL)HOMOSERINE LACTONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL POLARITY; CYTOKINE PRODUCTION; DENDRITIC CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

4-BUTYROLACTONE; ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; HOMOSERINE; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED NOD; PSEUDOMONAS AERUGINOSA; T-LYMPHOCYTE SUBSETS;

EID: 79961124098     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00032-11     Document Type: Article

References (30)

1. Alyanakian, M. A., et al. 2006. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55:179-185.
2. Bending, D., et al. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119:565-572.
3. Bras, A., and A. P. Aguas. 1996. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89:20-25. (Pubitemid 26284033)
4. + regulatory T cells. J. Immunol. 177:6603-6612.
5. Burton, O. T., et al. 2010. Importance of TLR2 in the direct response of T lymphocytes to Schistosoma mansoni antigens. Eur. J. Immunol. 40:2221-2229.
6. Cooke, A., et al. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21:169-176. (Pubitemid 29158763)
7. Drescher, K. M., K. Kono, S. Bopegamage, S. D. Carson, and S. Tracy. 2004. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329:381-394. (Pubitemid 39423987)
8. Feili-Hariri, M., and P. A. Morel. 2001. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin. Immunol. 98:133-142.
9. Gaisford, W., and A. Cooke. 2009. Can infections protect against autoimmunity? Curr. Opin. Rheumatol. 21:391-396.
10. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95:2979-2985.
11. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188.
12. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:285-322.
13. Kravchenko, V. V., et al. 2008. Modulation of gene expression via disruption of NF-κB signaling by a bacterial small molecule. Science 321:259-263. (Pubitemid 351989099)
14. La Flamme, A. C., K. Ruddenklau, and B. T. Backstrom. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71:4996-5004. (Pubitemid 37070742)
15. Lehuen, A., J. Diana, P. Zaccone, and A. Cooke. 2010. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 10:501-513.
16. + T cells and costimulatory pathways of T-cell activation in protection of non-obese diabetic (NOD) mice from diabetes. Immunology 96:600-605.
17. Pritchard, D. I., et al. 2005. Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactone. Acta Diabetol. 42:119-122. (Pubitemid 41551998)
18. Richer, M. J., N. Straka, D. Fang, I. Shanina, and M. S. Horwitz. 2008. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta. Diabetes 57:1302-1311.
19. Ritchie, A. J., et al. 2005. The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-cell activation. Infect. Immun. 73:1648-1655. (Pubitemid 40470753)
20. Ritchie, A. J., et al. 2007. The immunomodulatory Pseudomonas aeruginosa signalling molecule N-(3-oxododecanoyl)-L-homoserine lactone enters mammalian cells in an unregulated fashion. Immunol. Cell Biol. 85:596-602. (Pubitemid 350224204)
21. Ritchie, A. J., A. O. Yam, K. M. Tanabe, S. A. Rice, and M. A. Cooley. 2003. Modification of in vivo and in vitro T- and B-cell-mediated immune responses by the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone. Infect. Immun. 71:4421-4431. (Pubitemid 36919908)
22. Skindersoe, M. E., et al. 2009. Pseudomonas aeruginosa quorum-sensing signal molecules interfere with dendritic cell-induced T-cell proliferation. FEMS Immunol. Med. Microbiol. 55:335-345.
23. Tateda, K., et al. 2003. The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils. Infect. Immun. 71:5785-5793. (Pubitemid 37205632)
24. Telford, G., et al. 1998. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity. Infect. Immun. 66:36-42.
25. Tracy, S., and K. M. Drescher. 2007. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann. N. Y. Acad. Sci. 1103:143-151. (Pubitemid 46791110)
26. Veldhoen, M., et al. 2008. Transforming growth factor-beta "reprograms" the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341-1346.
27. Walsh, K. P., M. T. Brady, C. M. Finlay, L. Boon, and K. H. Mills. 2009. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J. Immunol. 183:1577-1586.
28. Zaccone, P., et al. 2010. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J. Biomed. Biotechnol. 2010:795210.
29. Zaccone, P., et al. 2003. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33:1439-1449. (Pubitemid 36609163)
30. Zaccone, P., et al. 2004. Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur. J. Immunol. 34:3246-3256. (Pubitemid 39549403)